AVNT vs CC: Which Stock Is the Better Buy?
Avient Corporation and The Chemours Company side by side — fundamentals from SEC filings, refreshed nightly. Sector: Basic Materials.
AI verdict — AVNT vs CC, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Avient Corporation (AVNT) | The Chemours Company (CC) | |
|---|---|---|
| Market cap | $3.2B | $3.1B |
| Revenue (latest FY) | $3.26B | $5.81B |
| Net income (latest FY) | $81.90M | $-386.00M |
| Revenue growth (5y CAGR) | 8.0% | 3.2% |
| Net margin | 2.5% | -6.6% |
| Return on equity | 3.4% | -154.4% |
| P/E ratio | 20.4 | — |
| Dividend yield | 3.1% | 1.7% |
| Profitable years (of last 10) | 9 | 7 |
| Positive free cash flow | Yes | Yes |
Verify the comparison
Use the filing period and source shown by each tool before treating two figures as comparable.
See the full AVNT vs CC breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open AVNT's full financials → Open CC's full financials →More comparisons
Frequently asked questions
Which is bigger, AVNT or CC?
Avient Corporation is larger by market capitalization — $3.2B versus $3.1B.
Which grows faster, AVNT or CC?
Over the last five fiscal years, Avient Corporation grew revenue faster — 8.0%/yr versus 3.2%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.
Keep exploring
AVNT fundamentals → · CC fundamentals → · All 1,500+ companies → · Free screener →